Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Foster

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Science Advances|August 29, 2025
Abnormal mitochondrial structure and function in brown adipose tissue of SLC35A4-MP knockout miceAndréa L Rocha, Christian Schmedt, Guy Perkins, et al.
Molecular Therapy Oncolytics|March 14, 2022
A novel fusion protein scaffold 18/12/TxM activates the IL-12, IL-15, and IL-18 receptors to induce human memory-like natural killer cellsCelia C Cubitt, Ethan McClain, Michelle Becker-Hapak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2025
First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid TumorsAnthony El-Khoueiry, Omar Saavedra, Jacob Thomas, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|October 7, 2025
ULTRA-Metrics: Delphi-Derived Framework for Assessing Ultrasound CompetencySteve Reid, Alberto Goffi, Ean Tsou, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Costimulatory domains direct distinct fates of CAR-driven T cell dysfunctionMehmet Emrah Selli, Jack H Landmann, Marina Terekhova, et al.
Blood|May 2, 2023
Costimulatory domains direct distinct fates of CAR-driven T-cell dysfunctionMehmet Emrah Selli, Jack H Landmann, Marina Terekhova, et al.
Blood|November 15, 2021
Phase 1/dose expansion trial of brentuximab vedotin and lenalidomide in relapsed or refractory diffuse large B-cell lymphomaJeffrey P Ward, Melissa M Berrien-Elliott, Felicia Gomez, et al.
The Journal of Clinical Investigation|May 28, 2024
Induced CD8α identifies human NK cells with enhanced proliferative fitness and modulates NK cell activationCelia C Cubitt, Pamela Wong, Hannah K Dorando, et al.
Blood|July 3, 2020
CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomasMargery Gang, Nancy D Marin, Pamela Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2021
Memory-like Differentiation Enhances NK Cell Responses to MelanomaNancy D Marin, Bradley A Krasnick, Michelle Becker-Hapak, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Science Advances|August 29, 2025
Abnormal mitochondrial structure and function in brown adipose tissue of SLC35A4-MP knockout miceAndréa L Rocha, Christian Schmedt, Guy Perkins, et al.
Molecular Therapy Oncolytics|March 14, 2022
A novel fusion protein scaffold 18/12/TxM activates the IL-12, IL-15, and IL-18 receptors to induce human memory-like natural killer cellsCelia C Cubitt, Ethan McClain, Michelle Becker-Hapak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2025
First-in-Human Phase I Study of a CD16A Bispecific Innate Cell Engager, AFM24, Targeting EGFR-Expressing Solid TumorsAnthony El-Khoueiry, Omar Saavedra, Jacob Thomas, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|October 7, 2025
ULTRA-Metrics: Delphi-Derived Framework for Assessing Ultrasound CompetencySteve Reid, Alberto Goffi, Ean Tsou, et al.
Biorxiv : the Preprint Server for Biology|February 7, 2023
Costimulatory domains direct distinct fates of CAR-driven T cell dysfunctionMehmet Emrah Selli, Jack H Landmann, Marina Terekhova, et al.
Blood|May 2, 2023
Costimulatory domains direct distinct fates of CAR-driven T-cell dysfunctionMehmet Emrah Selli, Jack H Landmann, Marina Terekhova, et al.
Blood|November 15, 2021
Phase 1/dose expansion trial of brentuximab vedotin and lenalidomide in relapsed or refractory diffuse large B-cell lymphomaJeffrey P Ward, Melissa M Berrien-Elliott, Felicia Gomez, et al.
The Journal of Clinical Investigation|May 28, 2024
Induced CD8α identifies human NK cells with enhanced proliferative fitness and modulates NK cell activationCelia C Cubitt, Pamela Wong, Hannah K Dorando, et al.
Blood|July 3, 2020
CAR-modified memory-like NK cells exhibit potent responses to NK-resistant lymphomasMargery Gang, Nancy D Marin, Pamela Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2021
Memory-like Differentiation Enhances NK Cell Responses to MelanomaNancy D Marin, Bradley A Krasnick, Michelle Becker-Hapak, et al.
Pageof 8